Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 2431-2440 of 3416 for cancer

Edit search filters
  1. A Study of Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura

    Rochester, MN

  2. A Study to Assess the Safety and Pharmacokinetics of GDC-8264 in Combination With Standard of Care in Participants With Acute Graft-Versus-Host Disease (aGVHD)

    Rochester, MN

  3. A Study of the Safety and Effectiveness of NEOD001 for Treating Previously Treated Patients with Persistent Cardiac Dysfunction Related to Light Chain Amyloidosis

    Jacksonville, FL, Rochester, MN

  4. The Affect of Low-Volume Bowel Preparation for Hospitalized Patients Colonoscopies

    Scottsdale/Phoenix, AZ

  5. A Study of PRX004 in Subjects With Amyloid Transthyretin (ATTR) Amyloidosis

    Rochester, MN

  6. A Study of the Impact of the Amount of Time Between the Collection of Whole Blood and the Isolation of the White Blood Cells

  7. Early Detection of Hemodynamic Decompensation in Humans

    Rochester, MN

  8. NEURO-TTRansform: A Study to Evaluate the Efficacy and Safety of AKCEA-TTR-LRx in Participants With Hereditary Transthyretin-Mediated Amyloid Polyneuropathy

    Rochester, MN

  9. Efficacy and Safety of ISIS-TTR Rx in Familial Amyloid Polyneuropathy

    Rochester, MN

  10. Using Laser Endomicroscopy to Predict Recurrence of Barrett's Esophagus

    Rochester, MN

.

Mayo Clinic Footer